olaparib,abiraterone
astrazeneca,merck
['gu ', 'pcsm', 'abira', 'olaparib', 'prostate', 'abiraterone', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
adding olaparib to first-line treatment with abiraterone extends overall survival in patients with metastatic castration-resistant prostate cancer, a phase 3 study presented at asco gu 2023 suggests. #gu23 #pcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.